Evolutionary Genomics, Inc. Stock Other OTC
Equities
FNAM
US30051F1012
Biotechnology & Medical Research
Financials (USD)
Sales 2021 | - | Sales 2022 | - | Capitalization | 4.66M |
---|---|---|---|---|---|
Net income 2021 | -2M | Net income 2022 | -1M | EV / Sales 2021 | - |
Net Debt 2021 | 3.53M | Net Debt 2022 | 3.17M | EV / Sales 2022 | - |
P/E ratio 2021 |
-1.34
x | P/E ratio 2022 |
-2
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 67.35% |
Managers | Title | Age | Since |
---|---|---|---|
Walter Messier
FOU | Founder | 69 | 90-10-31 |
Steve Warnecke
CEO | Chief Executive Officer | 68 | 10-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Steve Warnecke
CEO | Chief Executive Officer | 68 | 10-08-31 |
Mark Boggess
BRD | Director/Board Member | 64 | 09-12-31 |
Founder | 74 | 90-10-31 |
1st Jan change | Capi. | |
---|---|---|
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |